Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 351,357 |
|
|||||
| News | - | ||||||
| Day High | 979.98 | Low High |
|||||
| Day Low | 966.85 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Regeneron Pharmaceuticals Inc | REGN | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 5.80 | 0.60% | 973.80 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 970.00 | 966.85 | 979.98 | 973.80 | 968.00 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 15,500 | 351,357 | $ 974.41 | $ 342,366,238 | - | 684.805 - 998.325 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:27:15 | 1 | $ 973.00 | USD |
Regeneron Pharmaceuticals (REGN) Options Flow Summary
Regeneron Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 106.89B | 109.76M | - | 13.12B | 3.95B | 36.02 | 27.04 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Regeneron Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical REGN Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 926.94 | 979.98 | 926.94 | 960.99 | 393,710 | 46.86 | 5.06% |
| 1 Month | 911.55 | 979.98 | 875.225 | 913.74 | 507,390 | 62.25 | 6.83% |
| 3 Months | 953.44 | 998.325 | 875.225 | 943.99 | 460,823 | 20.36 | 2.14% |
| 6 Months | 806.88 | 998.325 | 783.57 | 907.77 | 518,829 | 166.92 | 20.69% |
| 1 Year | 756.36 | 998.325 | 684.805 | 838.42 | 526,539 | 217.44 | 28.75% |
| 3 Years | 497.52 | 998.325 | 492.13 | 705.14 | 645,728 | 476.28 | 95.73% |
| 5 Years | 323.56 | 998.325 | 271.37 | 587.42 | 768,672 | 650.24 | 200.96% |
Regeneron Pharmaceuticals Description
| Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases; Praluent for LDL cholesterol lowering; Dupixent in atopic dermatitis, asthma, and nasal polyposis; Libtayo in cutaneous squamous cell carcinoma; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal antibodies with Sanofi in immunology and cancer, and bispecific antibodies and antibody cocktails with other collaborators and independently. |
